참고문헌
- U.S. Department of State-Bureau of Consular Affairs. Frequently asked questions on COVID-19 vaccinations and testing for international travel [Internet]. Washington (DC): U.S. Department of State-Bureau of Consular Affairs; 2021 [cited 2021 Dec 30]. Available from: https://travel.state.gov/content/travel/en/international-travel/emergencies/covid-19-faqs-for-travel-to-the-us-information.html.
- Memish ZA, Alharthy A, Alqahtani SA, Karakitsos D. COVID-19 air travel restrictions and vaccine passports: an ongoing debate. Travel Med Infect Dis 2021;42:102049.
- Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 2021;397:671-81.
- Pormohammad A, Zarei M, Ghorbani S, et al. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines (Basel) 2021;9:467.
- Cazzola M, Rogliani P, Mazzeo F, Matera MG. Controversy surrounding the Sputnik V vaccine. Respir Med 2021;187:106569.
- Montalti M, Solda G, Di Valerio Z, et al. ROCCA observational study: early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance. EClinicalMedicine 2021;38:101027.
- Centers for Disease Control and Prevention. Domestic travel during COVID-19 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 Dec 30]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/travelers/travel-during-covid19.html.
- World Health Organization. COVID-19 advice for the public: getting vaccinated [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Dec 30]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice.
- World Health Organization. Interim statement on heterologous priming for COVID-19 vaccines [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Dec 30]. Available from: https://www.who.int/news/item/10-08-2021-interim-statement-on-heterologous-priming-for-covid-19-vaccines.
- UK Government. Red list of countries and territories [Internet]. London: UK Government; 2021 [cited 2021 Dec 30]. Available from: https://www.gov.uk/guidance/red-list-of-countries-and-territories.
- Ministere de l'Europe et des Affaires etrangeres. Entry requirements for individuals arriving from 'green' and 'orange' countries [Internet]. Paris: Ministere de l'Europe et des Affaires etrangeres; [date unknown] [cited 2021 Dec 30]. Available from: https://www.diplomatie.gouv.fr/en/coming-to-france/coming-to-france-your-covid-19-questions-answered/article/entry-requirements-for-individuals-arriving-from-green-red-orange-and-scarlet.
- Petersen E, Ntoumi F, Hui DS, et al. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529): highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis 2022;114:268-72.